CVE-2023-6518

CVE-2023-6518 is a high-severity vulnerability in Miateknoloji Mia-med with a CVSS 3.x base score of 7.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-256.

Key facts

Description

Plaintext Storage of a Password vulnerability in Mia Technology Inc. MİA-MED allows Read Sensitive Strings Within an Executable. This issue affects MİA-MED: before 1.0.7.

Frequently asked questions

What is CVE-2023-6518?
Plaintext Storage of a Password vulnerability in Mia Technology Inc. MİA-MED allows Read Sensitive Strings Within an Executable. This issue affects MİA-MED: before 1.0.7.
How severe is CVE-2023-6518?
CVE-2023-6518 has a CVSS 3.x base score of 7.5, rated high severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity none, and availability none.
Is CVE-2023-6518 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (36th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-6518?
CVE-2023-6518 affects Miateknoloji Mia-med. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2023-6518?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
Does CVE-2023-6518 have an EU (EUVD) identifier?
Yes. CVE-2023-6518 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2023-58749.
When was CVE-2023-6518 published?
CVE-2023-6518 was published on 2024-02-08 and last updated on 2026-06-17.

References

Affected products (1)

More vulnerabilities in Miateknoloji Mia-med

All CVEs affecting Miateknoloji Mia-med →

Other CWE-256 vulnerabilities

Browse all CWE-256 vulnerabilities →